trending Market Intelligence /marketintelligence/en/news-insights/trending/0cBjnB0z1eCGAXypHhnLTw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Hangzhou Just Biotherapeutics closes $57M financing

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery


Hangzhou Just Biotherapeutics closes $57M financing

Hangzhou Just Biotherapeutics Ltd. closed a $57 million series B financing led by Temasek Holdings (Pte) Ltd. (Unspecified Vehicle) and existing investors Lilly Asia Ventures and ARCH Venture Partners LLC.

New investors in the round included Taikang, Hangzhou Economic & Technological Development Area, Bank of China and Bank of Hangzhou.

The funds will be used to advance the company's product pipeline and to complete a research and manufacturing facility in China.